Mike Van is an Associate in Private Equity at Sofinnova, focusing on biopharmaceutical companies. He joined in 2022 as an Analyst and was promoted in 2024, with a PhD in Biology from Stanford.








At firms with a similar stage, sector and check size.





One email when Mike's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckMike Van is an Associate in Private Equity at Sofinnova, focusing on biopharmaceutical companies. He joined in 2022 as an Analyst and was promoted in 2024, with a PhD in Biology from Stanford.
Mike Van invests through Sofinnova Investments, which writes checks of $10M to $30M at series a, series b.
Email [email protected], the firm's inbox for founders, and name Mike in the subject. A warm intro from a founder Sofinnova Investments backed works better.
Last updated 2026-10-15. Is this you? Ask for a correction.